![How Elite Institutions were Affected By a Decade of Constricted Funding](https://cdn.cancerletter.com/media/2024/01/01224843/40-42-NCI-funding.png)
![How Elite Institutions were Affected By a Decade of Constricted Funding](https://cdn.cancerletter.com/media/2024/01/01224843/40-42-NCI-funding.png)
Cover Story
Free
By Will Craft and Matthew Bin Han Ong
The ten-year period of erosion that followed the doubling of the NIH budget has hit some research institutions harder than others.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Funding Opportunities
Drugs & Targets
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
![Drugs & Targets](https://cdn.cancerletter.com/media/2019/05/03161633/targets2.jpg)
Trending Stories
- Before the Olympics were smoke-free, tobacco brand deals ran rampant
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025
- Solving problems doctors can’t fix: How Georgetown’s medical-legal partnership saves lives by including lawyers on cancer care teams
Why every cancer center needs a Cancer LAW Project - ODAC vote will likely lead to three-arm and four-arm designs–and pragmatic trials–for perioperative indications
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch